Abstract
summary Background and aims: Little is known about the vitamin D status of patients with severe psychiatric disorders, a potential contributing factor to elevated rates of morbidity and mortality. This descriptive study assessed serum 25-hydroxyvitamin D [25(OH)D] levels in hospital patients with schizophreniaspectrum disorder, compared to a non-patient control group. Methods: Assessment of serum 25(OH)D levels in 20 acute care (� 60 days), 20 long-stay (� 6 months) adult public psychiatric hospital inpatients with schizophrenia-spectrum disorders, compared to 20 normal controls. Results: High rates of hypovitaminosis D were found in all three groups with no significant differences in
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
